Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoline Ehlert

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Mabs|January 21, 2016
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2Nikolai Siebert, Christin Eger, Diana Seidel, et al.
Cancers|July 14, 2023
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line TherapyHolger N Lode, Ruth Ladenstein, Sascha Troschke-Meurer, et al.
Cancers|October 20, 2018
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 TrialNikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, et al.
Mabs|November 10, 2017
Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHOIna Mueller, Karoline Ehlert, Stefanie Endres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphomaSandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Blood|March 28, 2012
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)Julia Pagel, Karin Beutel, Kai Lehmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Blood|December 14, 2011
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party studyJan Styczynski, Adriana Balduzzi, Lidia Gil, et al.
Human Mutation|May 26, 2020
ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsySarah H Elsea, Alexander Solyom, Kirt Martin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Mabs|January 21, 2016
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2Nikolai Siebert, Christin Eger, Diana Seidel, et al.
Cancers|July 14, 2023
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line TherapyHolger N Lode, Ruth Ladenstein, Sascha Troschke-Meurer, et al.
Cancers|October 20, 2018
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 TrialNikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, et al.
Mabs|November 10, 2017
Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHOIna Mueller, Karoline Ehlert, Stefanie Endres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphomaSandra Purz, Christine Mauz-Körholz, Dieter Körholz, et al.
Blood|March 28, 2012
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)Julia Pagel, Karin Beutel, Kai Lehmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Blood|December 14, 2011
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party studyJan Styczynski, Adriana Balduzzi, Lidia Gil, et al.
Human Mutation|May 26, 2020
ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsySarah H Elsea, Alexander Solyom, Kirt Martin, et al.
Pageof 5